Department of Pediatrics, University of British Columbia, Vancouver, Canada.
Department of Pediatrics, University of Toronto, Toronto, Canada.
J Thorac Cardiovasc Surg. 2016 Aug;152(2):498-504. doi: 10.1016/j.jtcvs.2016.03.085. Epub 2016 Apr 14.
The postoperative course of preterm babies undergoing surgical closure of a patent ductus arteriosus (PDA) is often complicated by postligation cardiac syndrome (PLCS). Despite targeted milrinone prophylaxis, some infants continue to experience postoperative respiratory deterioration. Our objective is to describe the immediate postoperative course and identify risk factors for respiratory instability when preterm infants undergoing PDA ligation are managed with targeted milrinone treatment.
A retrospective review of a cohort of infants undergoing PDA ligation between January, 2010 and August, 2013 was conducted. All infants had a targeted neonatal echocardiogram performed 1 hour after surgery. Infants received prophylactic milrinone treatment if the left ventricular output was <200 mL/kg/min. The primary outcome measure was the development of respiratory instability within 24 hours of surgery. Multivariable logistic regression was performed to identify predictors of respiratory instability.
Eighty-six infants with a median gestational age of 25 weeks (interquartile range [IQR], 24-26) and a birth weight of 740 g (IQR, 640-853) were included in this study. Forty-nine (57.0%) received milrinone prophylaxis. There were 44 (51.2%) infants who developed oxygenation or ventilation failure, and 7 (8.1%) neonates developed PLCS. Infants with longer isovolumic relaxation time (IVRT ≥30 milliseconds) were more likely to develop either oxygenation or ventilation failure.
Although the incidence of PLCS has declined after the introduction of targeted milrinone prophylaxis, many preterm infants continue to develop respiratory instability after surgical ligation. In this population, diastolic dysfunction manifested by prolonged IVRT could be associated with an adverse postoperative respiratory course.
接受动脉导管未闭(PDA)手术闭合的早产儿的术后过程常常因结扎后心脏综合征(PLCS)而复杂化。尽管有针对性的米力农预防措施,但一些婴儿仍会经历术后呼吸恶化。我们的目的是描述早产儿接受 PDA 结扎术时接受靶向米力农治疗的即刻术后过程,并确定呼吸不稳定的危险因素。
对 2010 年 1 月至 2013 年 8 月期间接受 PDA 结扎术的婴儿进行了回顾性队列研究。所有婴儿在手术后 1 小时进行靶向新生儿超声心动图检查。如果左心室输出量<200 mL/kg/min,则给予预防性米力农治疗。主要结局指标是术后 24 小时内发生呼吸不稳定的情况。采用多变量逻辑回归来确定呼吸不稳定的预测因素。
本研究共纳入 86 名中位胎龄为 25 周(四分位距 [IQR],24-26)和出生体重为 740 g(IQR,640-853)的婴儿。49 名(57.0%)接受了米力农预防治疗。有 44 名(51.2%)婴儿出现氧合或通气失败,7 名(8.1%)新生儿出现 PLCS。等容舒张时间(IVRT≥30 毫秒)较长的婴儿更有可能发生氧合或通气失败。
尽管在引入靶向米力农预防措施后,PLCS 的发生率有所下降,但许多早产儿在手术后仍会出现呼吸不稳定。在该人群中,舒张功能障碍表现为 IVRT 延长可能与术后呼吸不良有关。